ACYCLOVIR
- Product NDC
- 71205-371
- 11-digit product format
- 712050371
- Labeler code
- 71205
- Product ID
- 71205-371_32aa3f42-23a1-4867-8228-e6e76cf9f135
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ACYCLOVIR
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- ANDA074891
- Marketing category
- ANDA
- Marketing start
- 2013-08-08
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X4HES1O11F | ACYCLOVIR | 59277-89-3 | ACYCLOVIR |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71205-371-30 | 71205037130 | 30 TABLET in 1 BOTTLE (71205-371-30) | 30 tablet | 2022-02-08 | No | No | Historical |
| 71205-371-35 | 71205037135 | 35 TABLET in 1 BOTTLE (71205-371-35) | 35 tablet | 2022-02-08 | No | No | Historical |
| 71205-371-60 | 71205037160 | 60 TABLET in 1 BOTTLE (71205-371-60) | 60 tablet | 2022-02-08 | No | No | Historical |
| 71205-371-90 | 71205037190 | 90 TABLET in 1 BOTTLE (71205-371-90) | 90 tablet | 2022-02-08 | No | No | Historical |